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Abstract
This study explored the relationship between serum ferritin and hepcidin in athletes. Baseline serum ferritin levels of 54
athletes from the control trial of five investigations conducted in our laboratory were considered; athletes were grouped
according to values ,30 mg/L (SF,30), 30–50 mg/L (SF30–50), 50–100 mg/L (SF50–100), or .100 mg/L (SF.100). Data
pooling resulted in each athlete completing one of five running sessions: (1) 863 min at 85% vVO2peak; (2) 564 min at 90%
vVO2peak; (3) 90 min continuous at 75% vVO2peak; (4) 40 min continuous at 75% vVO2peak; (5) 40 min continuous at 65%
vVO2peak. Athletes from each running session were represented amongst all four groups; hence, the mean exercise duration
and intensity were not different (p.0.05). Venous blood samples were collected pre-, post- and 3 h post-exercise, and were
analysed for serum ferritin, iron, interleukin-6 (IL-6) and hepcidin-25. Baseline and post-exercise serum ferritin levels were
different between groups (p,0.05). There were no group differences for pre- or post-exercise serum iron or IL-6 (p.0.05).
Post-exercise IL-6 was significantly elevated compared to baseline within each group (p,0.05). Pre- and 3 h post-exercise
hepcidin-25 was sequentially greater as the groups baseline serum ferritin levels increased (p,0.05). However, post-exercise
hepcidin levels were only significantly elevated in three groups (SF30–50, SF50–100, and SF.100; p,0.05). An athlete’s iron
stores may dictate the baseline hepcidin levels and the magnitude of post-exercise hepcidin response. Low iron stores
suppressed post-exercise hepcidin, seemingly overriding any inflammatory-driven increases.
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Introduction
Recently, the mechanisms relating to iron deficiency in athletes
has been increasingly investigated, with a shift in focus from the
more traditionally accepted avenues of exercise-induced iron loss
such as hemolysis, sweating and gastrointestinal bleeding (for
review see [1]), to the influence of the iron regulatory hormone
known as hepcidin [2–4]. Recently, factors that may affect the
activity of this hormone such as training frequency, exercise
modality and nutritional practices have been established [5–7].
Hepcidin is a liver produced peptide, which acts to regulate iron
absorption from the intestine and recycling from the macrophage
via its interaction (internalisation and degradation) with the body’s
only known cellular iron exporter, ferroportin [8]. Increases in
hepcidin levels usually occur as a homeostatic response to
inflammatory stimuli (namely the inflammatory cytokine interleu-
kin-6: IL-6) or elevated iron levels [9], ultimately reducing dietary
iron absorption from the small intestine, and reducing the ability
of macrophages to recycle iron from senescent erythrocytes [10].
However, research investigating the time-course of exercise-
induced hepcidin response shows that the levels of this hormone
seem to peak some 3–6 h subsequent to the peak in IL-6 elevation
after an exercise bout [3]. No doubt, such timing is synonymous
with that at which an athlete may be consuming meals that
contain the majority of their dietary iron intake, and as such, it has
been suggested that elevated post-exercise hepcidin levels may
contribute to the high number of athletes commonly diagnosed
with iron deficiency [11].
Nevertheless, evidence from our laboratory initially proposed
that the hepcidin response of an athlete with compromised iron
levels may be different to that of an athlete with healthy iron stores
[3]. However, this paper assessed hepcidin in urine rather than
serum, and only showed three athletes presenting as non-hepcidin
responders in the post-exercise period; hence, statistical analysis on
this data became difficult. More recently, it was shown that 9
weeks of basic combat training resulted in reductions to the serum
ferritin levels of military personnel, without impacting on baseline
hepcidin levels [12]. However, these authors also reported that the
baseline hepcidin levels of soldiers presenting with compromised
iron stores were lower than those who presented with healthy serum
ferritin levels [12]. Subsequently, Auersperger et al., [13] also
showed a decline in serum ferritin and baseline hepcidin levels
within their group, after the completion of an 8 week exercise-
training intervention. Regardless, neither of these two investigations
[12,13] quantified the hepcidin response in the acute post-exercise
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period, when both low serum ferritin levels and exercise-induced
inflammation are present.
The prospect of an altered post-exercise hepcidin response in
iron deplete athletes is not obscure, since the inverse homeostatic
function of the body is to reduce the circulating levels of hepcidin
in response to low iron levels, hypoxia, or when iron is needed for
processes such as erythropoiesis [14]. For example, it has been
shown that the hepcidin response to a prolonged hypoxic exposure
is attenuated [15], possibly due to the impact of erythropoietin
(EPO) stimulation on the bone marrow to produce new red blood
cells [16], which requires the utilisation of the body’s iron stores.
However, it has also been suggested that EPO, hypoxia inducible
factors, or growth differentiation factors, all of which are increased
during hypoxia, may directly effect hepcidin expression [16,17].
Regardless, despite the proposition that the hepcidin response of
an iron-deplete athlete may be different to that of an athlete with
healthy iron stores, the exercise-induced inflammatory response
will still be evident in such athletes, posing the question of which
regulatory process (inflammation or low iron levels) will have the
over-riding influence on the subsequent post-exercise hepcidin
response.
As a result, it was the aim of this investigation to determine the
influence of an exercise stimulus on the acute post-exercise
hepcidin response of athletes characterised as iron deplete (serum
ferritin ,30 mg/L), and to compare this response to a group of
athletes with sub-optimal (serum ferritin 30–50 mg/L), healthy
(serum ferritin 50–100 mg/L), and high (serum ferritin .100 mg/
L) iron stores.
Methods
Ethics Statement
This study utilised pooled data from five separate investigations
conducted in our laboratory. Each investigation individually
received approval from the Human Ethics Committee of the
University of Western Australia conforming to the Declaration of
Helsinki on the use of human subjects. Written informed consent
was obtained from all participants prior to their participation in
each investigation. Only data from the control trial of each
investigation was used here. As a result, the data set is not
impacted by any intervention other than exercise.
Experimental Overview
The data of 54 trained runners or triathletes (38 males and 16
females) are represented below (sample population mean (6
standard deviation) for age: 25.8 (66.6) years; body mass: 67.1
(610.1) kg; stature: 174.2 (68.4) cm; and VO2peak: 60.1 (67.3)
ml/kg/min). All athletes presented as medically fit, with no
underlying health concerns. From this cohort, baseline serum
ferritin levels were considered, and the athletes were categorised
into four groups;
1. Serum ferritin ,30 mg/L (SF,30): n = 12 (4 male and 8
female)
2. Serum ferritin 30–50 mg/L (SF30–50): n = 8 (3 male and 5
female)
3. Serum ferritin 50–100 mg/L (SF50–100): n = 14 (13 male and 1
female)
4. Serum ferritin .100 mg/L (SF.100): n = 20 (18 male and 2
female)
It should be noted that a variety of cut-off values appear in the
literature for the determination of an iron deficiency in athletes
[1,2,12,18]. However, the upper limit of 30 mg/L for the SF,30
group in the current investigation is based on the standards for
determination of an iron deficiency as directed by the Royal
College of Pathologist Australasia [19]. Additionally, we have
distinguished a group of athletes that would be considered as
presenting with ‘sub-optimal’ iron status in an elite sport institute
setting, whereby the iron status of such an athlete would be
monitored over time. Garvican et al., [18] have described this as
‘sub-optimal’ ferritin levels, and recently used the upper limit cut-
off classification as 65 mg/L. Regardless, a more conservative
upper limit of 50 mg/L was used here to define this group.
Thereafter, based on the suggestions of Garvican et al., [18], the
final two groups were determined as athletes presenting with
healthy serum ferritin levels (50–100 mg/L), and those which
would be considered high in an athletic population (.100 mg/L).
Due to data pooling, it must be highlighted that the exercise
stimulus was varied between each investigation, such that there are
five different running sessions that participants may have
completed. However, due to standardised pre-testing protocols
from our laboratory, all participants were instructed not to
exercise during the 24 h pre-testing period, and a routine diet for
each individual throughout this time was encouraged. Further-
more, all running sessions were completed in the morning, thereby
avoiding any potential circadian influence. In all five investiga-
tions, the participants initially completed a running-based graded
exercise test (GXT), as per the method consistently used and
previously reported by our laboratory [4]. The GXT was used for
the determination of peak oxygen consumption (VO2peak) and the
associated running velocity (vVO2peak). Subsequently, the partic-
ipants then completed one of the following five running sessions on
a motorised treadmill in the laboratory:
N Interval Run 1 (INT1; n= 10): A 5 min warm-up at 60%
vVO2peak, followed by 863 min repeats at 85% vVO2peak
interspersed with 90 s of recovery between repetitions.
N Interval Run 2 (INT2; n= 12): A 5 min warm-up at 65%
vVO2peak, followed by 564 min repeats at 90% vVO2peak
interspersed with 90 s of recovery between repetitions.
N Long Slow Distance 1 (LSD1; n= 12): A 5 min warm-up at
60% vVO2peak, followed by a continuous 90 min run at 75%
vVO2peak.
N Long Slow Distance 2 (LSD2; n= 10): A 5 min warm-up at
60% vVO2peak, followed by a continuous 40 min run at 75%
vVO2peak.
N Long Slow Distance 3 (LSD3; n= 10): A 5 min warm-up at
60% vVO2peak, followed by a continuous 40 min run at 65%
vVO2peak.
During each of the above trials, heart rate (HR) was collected as
a measure of exercise intensity (Polar, Finland), which has been
compared and presented with exercise duration data below.
Although the exercise stimulus was varied between investigations,
the spread of athletes amongst the four classifications of iron status
was such that each running session and gender is represented
across the four groups. As a result, the mean exercise duration and
intensity of each group were similar (data presented below).
Blood collection protocols used here were consistent between
each of the five aforementioned investigations. Venous blood
samples were collected at three separate time points (pre-exercise,
post-exercise, and 3 h post-exercise) using a 21-gauge needle into
an 8.5 mL SST Gel separator tube. Serum samples were allowed
to clot for 60 min at room temperature, before subsequently being
centrifuged at 10uC and 3000 rpm for 10 min. Serum supernatant
was divided into 1 mL duplicate aliquots and stored at 280uC
until further analysis. Frozen serum samples were taken to the
Serum Ferrtin and Post-Exercise Hepcidin
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Royal Perth Hospital pathology laboratory to be analysed for
circulating levels of serum ferritin, serum iron, and IL-6 (pre- and
post-exercise). Furthermore, duplicate samples were sent to
Radboud University Medical Centre (Nijmegen, The Netherlands)
for serum hepcidin-25 analysis (pre- and 3 h post-exercise). The
specified time points for the analysis of each blood variable were
chosen to reflect their peak post-exercise activity from prior
research [3]. Details pertaining to the methods and laboratory-
specific precision of these assays have been previously reported by
our group, and are consistent across our investigations [6].
Statistical Analysis
Data are presented as mean and standard deviation (6SD),
unless otherwise stated. A series of one-way ANOVA for
independent samples were used to compare between group
differences for measures of exercise duration and intensity, serum
ferritin, serum iron, IL-6, and hepcidin responses. In the event of a
main effect, least significant difference post-hoc pairwise compar-
isons were made. Additionally, Pearson’s correlation coefficients
were calculated to describe any associations between blood
parameters. The alpha level was accepted at p#0.05.
Results
As a result of the spread of athletes from each running session
across the four groups, the mean running duration was
49614 min (SF,30); 51618 min (SF30–50); 57622 min
(SF50–100); and 63624 min (SF.100), with no significant
differences between groups (p = 0.30). Similarly, for running
intensity, the mean HR was 170611 bpm (SF,30);
163615 bpm (SF30–50); 167614 (SF50–100); and
169611 bpm (SF.100), also with no differences between groups
(p = 0.62).
The mean baseline and post-exercise serum ferritin and serum
iron levels are presented in Table 1. Significant between group
differences were evident for baseline (p = 0.01) and post-exercise
(p = 0.01) serum ferritin levels; however, there were no between
group differences for serum iron levels at either time point
(p = 0.82 and p= 0.71, respectively). The within group analysis
showed that serum ferritin was significantly elevated post-exercise
in all groups except SF,30 (SF,30: p = 0.06; SF30–50: p = 0.04;
SF50–100: p = 0.01; SF.100: p = 0.01); and that serum iron was
significantly increased in all groups except SF30–50 (SF,30:
p = 0.01; SF30–50: p = 0.10; SF50–100: p = 0.01; SF.100:
p = 0.01).
The pre- and post-exercise IL-6 levels are presented in Table 1.
No significant between group differences were found at either pre-
(p = 0.49) or post-exercise (p = 0.73). However, the post-exercise
IL-6 levels were significantly elevated compared to baseline within
each group (SF,30: p = 0.04; SF30–50: p = 0.02; SF50–100:
p = 0.01; SF.100: p= 0.01).
The pre- and 3 h post-exercise hepcidin-25 response is shown in
Figure 1. Significant between group differences were evident for
both the pre- (p = 0.01) and 3 h post-exercise (p = 0.01) levels,
Specifically, the pre-exercise hepcidin-25 level was sequentially
greater as the groups baseline serum ferritin levels increased
(SF,30 vs. SF30–50: p= 0.03; SF,30 vs. SF50–100: p = 0.01;
SF,30 vs. SF.100: p = 0.01; SF30–50 vs. SF.100: p = 0.01;
SF50–100 vs. SF.100: p= 0.01); however, this effect was not
evident when comparing SF30–50 to SF50–100 (p = 0.80).
Furthermore, the same response was evident 3 h post-exercise
(SF,30 vs. SF30–50: p= 0.04; SF,30 vs. SF50–100: p = 0.01;
SF,30 vs. SF.100: p = 0.01; SF30–50 vs. SF.100: p = 0.01;
SF50–100 vs. SF.100: p = 0.03), again with the effect not evident
when comparing SF30–50 to SF50–100 (p = 0.57). Interestingly,
the post-exercise hepcidin-25 levels were significantly greater than
baseline in SF30–50 (p = 0.03), SF50–100 (p= 0.01), and SF.100
(p = 0.01); however, this response was not evident (p = 0.10) in the
SF,30.
Baseline serum ferritin levels showed a strong positive associ-
ation to both the pre-exercise (r = 0.50; p = 0.01), and post-exercise
(r = 0.52; p = 0.01) hepcidin-25 levels. Figure 2 shows the baseline
serum ferritin and post-exercise hepcidin-25 association, in
addition to the individual athlete response. A similar association
was also seen between the post-exercise serum ferritin levels and
post-exercise hepcidin-25 (r = 0.53; p= 0.01). There were no
relationships found between measures of pre- or post-exercise IL-6
or serum iron with baseline or post-exercise hepcidin-25.
Discussion
The results of this investigation showed that an athlete’s iron
status may dictate both the pre-exercise levels of hepcidin, and also
the magnitude of hepcidin response to an acute exercise stimulus.
Additionally, although a significant and comparable post-exercise
IL-6 (suggesting an inflammatory response) and serum iron
(suggesting a haemolytic stimulus) increase was evident between
Table 1. Mean (6SD) baseline and post-exercise serum ferritin, serum iron, and Interleukin-6 levels in athletes grouped by serum
ferritin ,30 mg/L (SF,30), between 30–50 mg/L (SF30–50), between 50–100 mg/L (SF50–100), and .100 mg/L (SF.100).
Serum Ferritin Serum Iron Interleukin-6
Baseline Post-Exercise Baseline Post-Exercise Baseline Post-Exercise
Serum Ferritin mean 19.0 20.1 16.2 18.1{ 1.3 3.8{
,30 SD 5.5 5.0 7.0 7.0 2.4 6.1
Serum Ferritin mean 43.1 45.9{ 19.3 20.5 1.1 3.5{
30–50 SD 5.6 6.8 9.9 9.4 0.3 2.6
Serum Ferritin mean 69.9 75.5{ 17.8 20.1{ 1.7 4.3{
50–100 SD 13.5 17.7 8.4 8.2 2.1 2.8
Serum Ferritin mean 152.5 165.3{ 18.0 21.3{ 1.1 5.6{
.100 SD 56.6 62.1 4.9 5.9 1.0 6.7
{Significantly greater than pre-exercise.
doi:10.1371/journal.pone.0093002.t001
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groups, it would seem that low serum ferritin levels (and the lack of
post-exercise increase in this iron marker) were a greater stimulus
for the suppression of post-exercise hepcidin activity, overriding
the inflammatory-driven increases in hepcidin that were evident in
the SF30–50, SF50–100, and SF.100 groups. However, it was
also apparent that the increases to hepcidin levels were greatest in
the SF.100 group, further implying that the body regulates this
response relative to iron stores, with subtle reductions in the
hormone levels as the serum ferritin levels fall, until switching the
process off when the athlete reaches a point of compromised iron
status.
Supressed baseline hepcidin levels in iron deficient populations
comparative to healthy controls have been previously shown,
where iron deficient rodents were maintained on an iron deplete
Figure 1. Mean (± SE) pre-exercise and 3 h post-exercise hepcidin-25 levels in athletes with baseline serum ferritin levels ,30 mg/L
(SF,30), between 30–50 mg/L (SF30–50), between 50–100 mg/L (SF50–100), and .100 mg/L (SF.100). * Significantly greater than
SF,30. { Significantly greater than SF30–50. ` Significantly greater than SF50–100. ‘ Significantly greater than pre-exercise.
doi:10.1371/journal.pone.0093002.g001
Figure 2. Scatter plot and linear trend line of each individual’s 3 h post-exercise hepcidin response in association with their
baseline serum ferritin levels (r = 0.52; p=0.01).
doi:10.1371/journal.pone.0093002.g002
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diet (3 mg/kg wet weight), or healthy controls on an iron replete
diet (159 mg/kg wet weight) for 6 weeks, whilst measuring the
levels of hepcidin gene expression both before, and after treatment
with lipopolysaccharide to induce inflammation [20]. These
authors showed that the baseline hepcidin levels in the iron
deficient group were significantly lower than those with normal
iron stores. Furthermore, strong positive correlations between
baseline serum ferritin and hepcidin levels amongst various
populations of healthy individuals, and/or patients showing
inflammatory disorders or iron overload have previously been
shown [21–23]. As a result, the lower baseline levels of hepcidin
reported here in the iron deficient group are not uncommon;
however, the sequential increase in the resting levels of this
hormone in relation to the baseline iron stores in an athletic
population is novel, and suggests that the body’s underlying
mechanism controlling the absorption and recycling of iron
responds appropriately at rest in the absence of an acute-phase
inflammatory stimulus such as exercise.
When considering the post-exercise responses seen in this study
however, it was evident that all four groups incurred a significant
inflammatory stimulus from the exercise task. Subsequently, it
appeared that the hepcidin levels were again sequentially higher as
the baseline iron status of the athletes increased. Of interest
however, is the fact that the elevations in hepcidin levels were not
present in the iron deficient group. Increased hepcidin levels in
response to an inflammatory stimulus has precedence in previous
research reporting on unhealthy patients with anaemia of
inflammation, who showed significantly greater circulating
hepcidin levels compared to those of healthy controls and to
individuals with iron deficiency [22]. The same differences were
also reported between rheumatoid arthritis patients with inflam-
matory associated anaemia of chronic disease and those with iron
deficiency [24]. Furthermore, when rodents were treated with
lipopolysaccharide to induce inflammation, it was shown that the
subsequent increase in hepcidin gene expression was significantly
lower in an iron deficient group compared to healthy controls
[20]. These authors suggested that although the inflammatory
response invoked in their study was a strong inducer of hepcidin
expression, chronic iron deficiency seemed able to counteract this
effect. Such conclusions are reinforced by the findings that
hepcidin levels in iron deficient and anaemic children with
elevated inflammatory markers were significantly lower than those
in non-anaemic children presenting with the same inflammatory
state [25]. These authors concluded that the inflammatory-
mediated stimuli are overridden by iron demand and erythropoi-
esis, which in turn, down regulates hepcidin synthesis [25]. The
culmination of these previous findings in non-athletic populations
provides justification for the sequentially higher pre- and post-
exercise hepcidin levels seen here as the baseline iron status of the
athletes increased, and for the non-response of the SF,30 group.
Similar to the investigations of populations presenting with
inflammation from chronic disease, numerous exercise trials have
shown significant post-exercise increases to circulating hepcidin
levels in response to the inflammatory-driven increases in IL-6
[3,4,26]. However, the results from previous exercise-based studies
have sporadically reported cases of hepcidin non-responders
within the populations sampled [2,3], with the suggestion that
these participants may have been iron deficient. More recent work
has supported this observation in longer-term training interven-
tions, with lower baseline hepcidin levels reported in association
with low serum ferritin levels [12,13]. Regardless, in each of these
past studies, the total number of confirmed iron deficient
participants has either been very low [3], the iron status of the
athletes was not measured [2], or the influence of these baseline
measures was not considered in association with the acute post-
exercise response [12,13]. As a result, the current investigation
highlights the post-exercise hepcidin response of a larger iron
deficient athletic population, confirming that low baseline iron
stores could explain the hepcidin non-responders seen in this
previous research.
The post-exercise hepcidin responses reported here imply a
sequential increase in activity positively associated with the
baseline iron status of the athlete, irrespective of the inflammatory
stimulus created by the exercise task. Again, this outcome suggests
that hepcidin is responding to maintain iron homeostasis, sensing
the need for increased dietary iron absorption as the serum ferritin
levels of the athlete decrease. However, based on recent literature
investigating the iron status of well-trained athletes [18], the
baseline iron stores of the SF30–50 group (mean: 43.1 mg/L) can
be considered ‘sub-optimal’; yet a post-exercise hepcidin response
was still evident after 3 h of recovery in this group, which is of
similar magnitude to those athletes presenting with healthy iron
stores. Previously, an increase in hepcidin response by females
presenting with sub-optimal (mean serum ferritin: 42 mg/L) iron
stores has been shown [23]. These authors showed an increase in
hepcidin levels as a result of greater iron availability through oral
iron administration, suggesting that hepcidin suppression in
individuals with low serum ferritin levels is attenuated, and that
hepcidin concentrations may still increase despite low body iron
stores. Unfortunately, the 3 h post-exercise time frame for
hepcidin elevations seen here may coincide with an athlete’s meal
consumption that contains the majority of their dietary iron intake
following a training session. As a result, it is possible that the post-
exercise elevations in hepcidin activity are of most concern to
athletes that present with a ‘sub-optimal’ iron status (i.e. those with
serum ferritin levels ,30–50 mg/L), since it is in these athletes
where a significant post-exercise elevation in hepcidin will still
occur, potentially reducing their ability to recycle and absorb iron
from the diet, thereby increasing the likelihood that an iron
deficiency may develop over time.
Although novel and interesting, it must be acknowledged that
the exercise stimulus in this investigation was not standardised
between all participants. However, all exercise trials were
represented across the four serum ferritin groups, with the
statistical analysis suggesting no significant differences for exercise
duration or intensity between trials. Additionally, it should also be
considered that the universal cut-off for defining an iron deficiency
in athletes remains elusive. Regardless, the serum ferritin groups
established here are based on recent literature [18,19], and fit
within the scope of previous work related to athletic-induced iron
deficiency [1–7,12,18]. Finally, it should also be acknowledged
that the influence of gender on this acute post-exercise response is
not well understood. However, as a level of control, it should be
noted that in each of our investigations, female athletes were only
tested in the follicular phase of their menstrual cycle. Regardless,
due to the influence that baseline serum ferritin has been shown to
play here, a larger sample size of both genders with similar
baseline serum ferritin levels would be required to investigate any
gender differences appropriately, and as such, cannot be
completed from the current data set. To this end, the results
presented here should be interpreted with these considerations in
mind, setting the scene for future research to further explore the
influence of exercise intensity and duration, the cut-offs for iron
status, and the gender effects on the haematological responses in
athletes with varying degrees of iron status.
Serum Ferrtin and Post-Exercise Hepcidin
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Conclusion
In summary, applied sports physicians, dietitians and physiol-
ogists working with iron deficient athletes should continue to focus
on increasing iron stores through food choices and oral
supplementation; or via intramuscular and intravenous iron
injections (in conjunction with attaining any appropriate Thera-
peutic Use Exemptions from governing anti-doping agencies).
Furthermore, the training load and impact nature of the exercise
prescribed to such athletes also needs to be considered, taking into
account the potential influence of hemolysis on iron stores from
different exercise modalities [4,27]. However, if working with
athletes that present with a ‘sub-optimal’ iron status (serum ferritin
30–50 mg/L), the focus should not only be on the supplementation
of iron sources, but also on the timing of this supplementation, in
order to avoid the peak periods of hepcidin elevation post-exercise.
Acknowledgments
The Authors would like to acknowledge Harold Tjalsma, Christopher
Gore, Laura Garvican, Gregory Cox, Grant Landers and Carmel
Goodman for their previous contributions to our work in this area.
Author Contributions
Conceived and designed the experiments: PP BD CRA DT. Performed the
experiments: MS CEB ADG PP BD. Analyzed the data: PP MS ADG
CEB BD CRA DWS DT. Contributed reagents/materials/analysis tools:
PP MS ADG CEB BD CRA DWS DT. Wrote the paper: PP MS ADG
CEB BD CRA DWS DT.
References
1. Peeling P, Dawson B, Goodman C, Landers G, Trinder D (2008) Athletic
induced iron deficiency: new insights into the role of inflammation, cytokines
and hormones. Eur J Appl Physiol 103: 381–91.
2. Roecker L, Meier-Buttermilch R, Brechtel L, Nemeth E, Ganz T (2005) Iron-
regulatory protein hepcidin is increased in female athletes after a marathon.
Eur J Appl Physiol 95: 569–571.
3. Peeling P, Dawson B, Goodman C, Landers G, Wiegerinck ET, et al. (2009a)
Effects of exercise on hepcidin response and iron metabolism during recovery.
Int J Sport Nutr Exerc Metab 19: 583–597.
4. Peeling P, Dawson B, Goodman C, Landers G, Wiegerinck ET, et al. (2009b)
Training Surface and Intensity: Inflammation, Hemolysis and Hepcidin
Expression. Med Sci Sport Exerc 41: 1138–1145.
5. Peeling P, Dawson B, Goodman C, Landers G, Wiegerinck ET, et al. (2009c)
Cumulative effects of consecutive running sessions on hemolysis, inflammation
and hepcidin activity. Eur J Appl Physiol 106: 51–59.
6. Sim M, Dawson B, Landers G, Wiegerinck ET, Swinkels DW, et al. (2012) The
effects of carbohydrate ingestion during endurance running on post–exercise
inflammation and hepcidin levels. Eur J Appl Physiol 112: 1889–1898.
7. Sim M, Dawson B, Landers G, Swinkels DW, Tjalsma H, et al. (2013) Effect of
exercise modality and intensity on post-exercise interleukin-6 and hepcidin
levels. Int J Sport Nutr Exerc Metab 23: 178–186.
8. Nemeth E, Tuttle MS, Powelson J, Vaughn MB, Donovan A, et al. (2004a)
Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its
internalization. Science 306: 2051–2053.
9. Nemeth E, Rivera S, Gabayan V, Keller C, Taudorf S, et al. (2004b) IL-6
mediates hypoferremia of inflammation by inducing the synthesis of the iron
regulatory hormone hepcidin. J Clin Invest 113: 1271–1276.
10. Ganz T (2011) Hepcidin and iron regulation, 10 years later. Blood 117: 4425–
4433.
11. Peeling P (2010) Exercise as a mediator of hepcidin activity in athletes. Eur J Appl
Physiol 110: 877–883.
12. Karl JP, Lieberman HR, Cable SJ, Williams KW, Young AJ, et al. (2010)
Randomized, double-blind, placebo-controlled trial of an iron-fortified food
product in female soldiers during military training: relations between iron status,
serum hepcidin, and inflammation. Am J Clin Nutr 92: 93–100.
13. Auersperger I, Knap B, Jerin A, Blagus R, Lainscak M, et al. (2012) The effects
of 8 weeks of endurance running on hepcidin concentrations, inflammatory
parameters, and iron status in female runners. Int J Sport Nutr Exerc Metab 22:
55–63.
14. Kroot JJC, Tjalsma H, Flemming RE, Swinkels DW (2011) Hepcidin in human
iron disorders: Diagnostic implications. Clin Chem 57: 1650–1669.
15. Talbot NP, Lakhal S, Smith TG, Privat C, Nickol AH, et al. (2012) Regulation
of hepcidin expression at high altitude. Blood 119: 857–860.
16. Lui Q, Davidoff O, Niss K, Haase VH (2012) Hypoxia-inducible factor regulates
hepcidin via erythropoietin-induced erythropoiesis. J Clin Invest 122: 4635–
4644.
17. Piperno A, Galimberti S, Mariani R, Pelucchi S, Ravasi G, et al. (2011)
Modulation of hepcidin production during hypoxia-induced erythropoiesis in
humans in vivo: data from the HIGHCARE project. Blood 117: 2953–2959.
18. Garvican LA, Saunders PU, Cardoso T, Macdougall IC, Lobigs LM, et al.
(2014) Intravenous iron supplementation in distance runners with low or
suboptimal ferritin. Med Sci Sports Exerc 46: 376–385.
19. RCPA (2013) Iron studies standardised reporting protocol. The Royal College of
Pathologists Australasia. Surry Hills, NSW, Australia.
20. Darshan D, Frazer DM, Wilkins SJ, Anderson GJ (2010) Severe iron deficiency
blunts the response of the iron regulatory gene Hamp and pro-inflammatory
cytokines to lipopolysaccharide. Haematologica 95: 1660–1667.
21. Galesloot TE, Vermeulen SH, Geurts-Moespot AJ, Klaver SM, Kroot JJ, et al.
(2011) Serum hepcidin: reference ranges and biochemical correlates in the
general population. Blood 117: e218–25.
22. Nemeth E, Valore EV, Territo M, Schiller G, Lichtenstein A, et al. (2003)
Hepcidin, a putative mediator of anemia of inflammation, is a type II acute-
phase protein. Blood 101: 2461–2463.
23. Schaap CC, Hendriks JC, Kortman GA, Klaver SM, Kroot JJ, et al. (2013)
Diurnal rhythm rather than dietary iron mediates daily hepcidin variations. Clin
Chem 59: 527–535.
24. van Santen S, van Dongen-Lases EC, de Vegt F, van Riel PL, van Ede AE, et al.
(2011) Hepcidin and hemoglobin content parameters in the diagnosis of iron
deficiency in rheumatoid arthritis patients with anemia. Arthritis Rheum 63:
3672–3680.
25. Jaeggi T, Moretti D, Kvalsvig J, Holding PA, Tjalsma H, et al. (2013) Iron status
and systemic inflammation, but not gut inflammation, strongly predict gender-
specific concentrations of serum hepcidin in infants in rural Kenya. PLoS One
8:e57513.
26. Robson-Ansley P, Walshe I, Ward D (2011) The effect of carbohydrate ingestion
on plasma interleukin-6, hepcidin and iron concentrations following prolonged
exercise. Cytokine 53: 196–200.
27. Telford RD, Sly GJ, Hahn AG, Cunningham RB, Bryant C, et al. (2003)
Footstrike is the major cause of hemolysis during running. J Appl Physiol 94: 38–
42.
Serum Ferrtin and Post-Exercise Hepcidin
PLOS ONE | www.plosone.org 6 March 2014 | Volume 9 | Issue 3 | e93002
